﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v6.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-08-04T09:54:10-05:00</ReturnTs>
    <TaxPeriodEndDt>2024-09-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>420714325</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>RSM US LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1001 WATER ST STE 500</AddressLine1Txt>
        <CityNm>TAMPA</CityNm>
        <StateAbbreviationCd>FL</StateAbbreviationCd>
        <ZIPCd>33602</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-10-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>521238026</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>AMERICAN INSTITUTE FOR CANCER RESEARCH</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>2023287744</PhoneNum>
      <USAddress>
        <AddressLine1Txt>1560 WILSON BOULEVARD 425</AddressLine1Txt>
        <CityNm>ARLINGTON</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>22209</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JOHN MCCALLA</PersonNm>
      <PersonTitleTxt>SECRETARY</PersonTitleTxt>
      <PhoneNum>2023287744</PhoneNum>
      <SignatureDt>2025-07-31</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>KRISTEN BARNETT</PreparerPersonNm>
      <PTIN>P01234578</PTIN>
      <PhoneNum>8133162300</PhoneNum>
      <PreparationDt>2025-07-31</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="11">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>JOHN MCCALLA</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>1560 WILSON BOULEVARD 425</AddressLine1Txt>
        <CityNm>ARLINGTON</CityNm>
        <StateAbbreviationCd>VA</StateAbbreviationCd>
        <ZIPCd>22209</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>13516921</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.AICR.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1981</FormationYr>
      <LegalDomicileStateCd>DC</LegalDomicileStateCd>
      <ActivityOrMissionDesc>AICR'S PRIMARY OBJECTIVES ARE TO PROMOTE, EXPAND, AND ENCOURAGE PUBLIC KNOWLEDGE ON HOW THE RISK OF CANCER IS REDUCED BY HEALTHY FOOD AND NUTRITION, PHYSICAL ACTIVITY, AND WEIGHT MANAGEMENT, THE CAUSES AND TREATMENT OF CANCER IN GENERAL, AND TO FUND, SUPPORT, AND ENCOURAGE INNOVATIVE SCIENTIFIC RESEARCH AS TO THE CAUSES, PREVENTION, AND TREATMENT OF CANCER.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>5</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>5</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>41</TotalEmployeeCnt>
      <TotalVolunteersCnt>25573</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>10094745</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>8592095</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1281556</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1280717</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>354155</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>692898</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>155338</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>143680</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>11885794</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>10709390</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>1435966</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>1393198</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>3284102</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>2536887</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>353328</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>484998</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>2308101</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>7276731</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>6149806</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>12350127</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>10564889</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-464333</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>144501</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>17918349</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>17919717</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>5675747</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>4615514</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>12242602</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>13304203</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>AICR CHAMPIONS THE LATEST AND MOST AUTHORITATIVE SCIENTIFIC RESEARCH FROM AROUND THE WORLD ON CANCER PREVENTION AND SURVIVAL THROUGH DIET, WEIGHT AND PHYSICAL ACTIVITY, SO THAT WE CAN HELP PEOPLE MAKE INFORMED LIFESTYLE CHOICES TO REDUCE THEIR CANCER RISK.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>4693345</ExpenseAmt>
      <GrantAmt>407044</GrantAmt>
      <RevenueAmt>1263074</RevenueAmt>
      <Desc>SEE SCHEDULE O. EDUCATIONEDUCATION PROGRAMSTHE AMERICAN INSTITUTE FOR CANCER RESEARCH (AICR) CHAMPIONS THE LATEST AND MOST AUTHORITATIVE SCIENTIFIC RESEARCH ON CANCER PREVENTION AND SURVIVAL THROUGH DIET, WEIGHT AND PHYSICAL ACTIVITY SO THAT WE CAN HELP PEOPLE MAKE INFORMED LIFESTYLE CHOICES TO REDUCE THEIR RISK. WE WANT TO LIVE IN A WORLD WHERE NO ONE DEVELOPS A PREVENTABLE CANCER. EDUCATION: AICR'S MESSAGEAICR'S EDUCATION PROGRAMS ARE EVIDENCE-BASED. THIS EVIDENCE COMES FROM BOTH THE RESEARCH WE FUND, AND THE CONCLUSIONS DRAWN IN OUR SCIENTIFIC REPORTS. FROM THESE FINDINGS WE PRODUCE EDUCATIONAL MATERIALS TO MEET A WIDE VARIETY OF NEEDS, ACROSS ALL STAGES OF THE CANCER CONTINUUM. BROCHURES AND FACT SHEETSDEVELOPED TO PUT THE LATEST CANCER RESEARCH FINDINGS IN A CONCISE FORMAT, AICR'S BROCHURES, LEAFLETS AND FACT SHEETS OFFER MANY DIFFERENT AUDIENCES OUR EMPOWERING MESSAGE THAT WE CAN TAKE STEPS TO REDUCE OUR OWN CANCER RISK. FOLLOWING THE LAUNCH OF OUR THIRD EXPERT REPORT IN MAY 2018, ALL THESE RESOURCES WERE REVIEWED AND UPDATED TO REFLECT THE MOST CURRENT SCIENTIFIC EVIDENCE.INDIVIDUALS CAN ORDER SINGLE FREE COPIES; HEALTH PROFESSIONALS AND MEDICAL CENTERS (E.G., HOSPITALS, CANCER CLINICS, ETC.) CAN MAKE BULK PURCHASES. AICR ALSO DISTRIBUTES BROCHURES AT CONFERENCES, EVENTS AND HEALTH FAIRS.HEALTH AIDSAICR PRODUCES HEALTH AIDS, INCLUDING INFOGRAPHICS, DOWNLOADABLES INFORMATION CARDS, MAGNETS AND MORE TO TURN LOWERING CANCER RISK INTO A "HANDS-ON" EXPERIENCE. INDIVIDUALS CAN ORDER SINGLE FREE COPIES; HEALTH PROFESSIONALS AND MEDICAL CENTERS (HOSPITALS, CANCER CLINICS, ETC.) CAN MAKE BULK PURCHASES. AICR ALSO DISTRIBUTES HEALTH AIDS AT CONFERENCES, EVENTS AND HEALTH FAIRS.AICR WEBSITETHE GOAL OF THE AICR WEBSITE (WWW.AICR.ORG) IS TO INSPIRE USERS TO TAKE CONTROL OF THEIR HEALTH USING RESEARCH-BACKED CANCER PREVENTION AND SURVIVORSHIP RESOURCES. THE WEBSITE OFFERS UPDATED INFORMATION ON AICR RESEARCH; HEALTHY, CANCER-PROTECTIVE RECIPES AND FITNESS TIPS; AND A HOST OF INTERACTIVE TOOLS AND RESOURCES ON THE SCIENCE OF LOWERING CANCER RISK.AICR'S WEBSITE ALSO INCLUDES INSPIRING STORIES OF IMPACT. THESE ARE TESTIMONIALS BY HEALTH PROFESSIONALS WHO REGULARLY USE AICR'S VARIOUS RESOURCES TO BUILD HEALTHIER COMMUNITIES THROUGH CANCER CENTERS, SURVIVORSHIP PROGRAMS AND MORE. ONE ONCOLOGY NUTRITIONIST AT THE DEMPSEY CENTER IN MAINE PROVIDES NUTRITION CONSULTATIONS TO PEOPLE WITH A CANCER DIAGNOSIS AND THEIR CARE PARTNERS; A REGISTERED DIETITIAN AT THE VCU MASSEY CANCER CENTER IN VIRGINIA USES AICR'S RESOURCES TO PROVIDE CANCER PATIENTS AND SURVIVORS WITH INFORMATION ABOUT WHAT TO EAT AND WHY WE EAT FOR WELLNESS. AND YET ANOTHER REGISTERED DIETITIAN AT PENN MEDICINE'S ABRAMSON CANCER CENTER IN PENNSYLVANIA HELPS CANCER PATIENTS NAVIGATE THE RELATIONSHIP BETWEEN NUTRITION, TREATMENT AND POST-TREATMENT QUALITY OF LIFE.THERE ARE ALSO TESTIMONIALS BY PEOPLE WHO HAVE BEEN DIRECTLY AFFECTED BY CANCER OR KNOW SOMEONE WHO HAS BEEN AFFECTED BY CANCER, AND HOW THEY HAVE USED AICR'S RESOURCES TO HELP THEMSELVES OR OTHERS NAVIGATE CANCER FROM DIAGNOSIS THROUGH SURVIVORSHIP. ONE INSPIRING STORY IS FROM A BREAST CANCER SURVIVOR WHO WAS DIAGNOSED WHILE PREGNANT. AFTER SURGERY, CHEMO, RADIATION AND DELIVERING A HEALTHY BABY, SHE JOINED TEAM AICR AND RAN THE LONDON MARATHON TO RAISE AWARENESS OF AICR'S MESSAGE ABOUT THE IMPORTANCE OF PHYSICAL ACTIVITY AND TO RAISE FUNDS IN SUPPORT OF CANCER RESEARCH AT AICR.E-PUBLICATIONAICR'S MONTHLY NEWSLETTER, CANCER FOCUS, ENCOMPASSES THREE AREAS: HOW TO START LIVING FOR LOWER CANCER RISK TODAY; BREAKING NEWS AND CURRENT RESEARCH IN THE FIGHT AGAINST CANCER; AND RESEARCH, RECIPES AND FOODS THAT HELP SURVIVORS NAVIGATE THEIR CANCER JOURNEY. AS OF SEPTEMBER 2024, NEARLY 1.5 MILLION COPIES OF CANCER FOCUS HAVE BEEN DISTRIBUTED.AICR BLOG AND SOCIAL MEDIATHE AICR BLOG (AICR.ORG/RESOURCES/BLOG) SPEAKS TO SUPPORTERS; CANCER PATIENTS, SURVIVORS AND CAREGIVERS; HEALTH PROFESSIONALS; THE MEDIA AND THE GENERAL PUBLIC. THE AICR BLOG IS ONE WAY AICR ENGAGES IN AN ONGOING DISCUSSION ABOUT RESEARCH AND SEPARATES CANCER MYTHS FROM CANCER FACTS, ESPECIALLY THOSE THAT ARE HOT TOPICS IN THE MEDIA. IT IS WHERE WE SHAREOUR TAKE ON CURRENT NEWS AND ENCOURAGE READERS TO POST COMMENTS. INFY24, THE AICR BLOG RECEIVED NEARLY 548,000 PAGE VIEWS. FACEBOOK AND TWITTER HAVE HISTORICALLY BEEN IMPORTANT COMMUNICATION CHANNELS FOR AICR TO SHARE MESSAGES WITH A WIDE AND DIVERSE AUDIENCE. IN ADDITION TO FACEBOOK AND TWITTER, AICR INCREASED SOCIAL MEDIA EFFORTS IN FY24 TO HELP GROW OUR BRAND ON INSTAGRAM, LINKEDIN, PINTEREST AND YOUTUBE. AT THE END OF FY24, AICR HAD A TOTAL OF 66,279 SOCIAL MEDIA FOLLOWERS FOR 10.9% GROWTH COMPARED TO FY23. OVER THE COURSE OF FY24 AICR SOCIAL MEDIA CHANNELS HAD A TOTAL OF 1,273,118 IMPRESSIONS AND 62,122 ENGAGEMENTS, 21.8% MORE ENGAGEMENTS OVER FY23. AT THE CLOSE OF FY24, AICR'S FACEBOOK PAGE HAD 27,157 FOLLOWERS. TWITTER (@AICRTWEETS) HAD 7,956 FOLLOWERS AND LINKEDIN HAD 17,910.CANCER PREVENTION MONTHFEBRUARY IS CANCER PREVENTION MONTH TO RAISE AWARENESS THAT 40% OF CANCERS CAN BE PREVENTED AND PROVIDE EMPOWERING MESSAGES TO HELP CANCER SURVIVORS TAKE CONTROL OF THEIR HEALTH. WE ENCOURAGED PEOPLE TO "TAKE THE TEN" AN ONLINE TOOL (AICR'S HEALTHY10 CHALLENGE) TO HELP PEOPLE CHANGE THEIR LIFESTYLE HABITS AND PUT AICR'SCANCER PREVENTION RECOMMENDATIONS INTO ACTION. THE HEALTHY10 CHALLENGE IS A FREE, 10-WEEK INTERACTIVE PROGRAM DESIGNED TO HELP INDIVIDUALS IMPROVE THEIR DIET, NUTRITION, PHYSICAL ACTIVITY AND WEIGHT FOR LOWER CANCER RISK AND BETTER OVERALL HEALTH. AT THE END OF SEPTEMBER 2024, ALMOST 6,000 INDIVIDUALS HAD SIGNED UP FOR THE CHALLENGE. IN FEBRUARY 2024, AICR'S WEBSITE HAD OVER 103,343 USERS, 443 PEOPLE TOOK THE CANCER HEALTH CHECK AND AICR ACQUIRED OVER 774 NEW EMAIL ADDRESSES. AICR'S SOCIAL MEDIA PLATFORMS GAINED 639 NEW FOLLOWERS, EARNED OVER 96,002 IMPRESSIONS AND RECEIVED NEARLY 4,900 ENGAGEMENTS.HEALTHY10 CHALLENGEAICR'S EVIDENCE-BASED MATERIALS HELP PEOPLE LEARN ABOUT WHAT THEY CAN DO TO PROTECT THEMSELVES FROM CANCER, BUT WE ALSO SUPPLY THEM WITH TOOLS THAT SUPPORT THE KIND OF REAL, LASTING BEHAVIOR CHANGE THAT LEADS TO LOWER RISK. THE HEALTHY10 CHALLENGE IS A 10-WEEK, FREE, INTERACTIVE, ONLINE PROGRAM TO HELP USERS IMPROVE THEIR DIET, NUTRITION, PHYSICAL ACTIVITY AND WEIGHT FOR LOWER CANCER RISK AND BETTER OVERALL HEALTH. IT IS BASED ON AICR'S EVIDENCE-BASED CANCER PREVENTION RECOMMENDATIONS AND IS INTENDED FOR ADULTS WANTING TO REDUCE THEIR CANCER RISK (INCLUDING RECURRENCE AND SECONDARY CANCER). ITS MOTIVATIONAL CHALLENGES ALTERNATE BETWEEN DIET AND PHYSICAL ACTIVITY TO HELP USERS EAT SMARTER AND MOVE MORE. EACH WEEK USERS WILL BE GIVEN A GOAL AS WELL AS TIPS AND TOOLS TO HELP CONQUER EACH CHALLENGE. THIS IS A SIMPLE AND FUN WAY TO BECOME HEALTHIER AND TAKE ACTION TO REDUCE CANCER RISK AT ANY STAGE OF LIFE AND MEETS INDIVIDUALS WHERE THEY ARE AT IN THEIR HEALTH JOURNEY. THERE WAS A TOTAL OF OVER 5,870 EMAILS COLLECTED AND INDIVIDUALS WHO SIGNED UP FOR THE HEALTHY10 CHALLENGE IN FY24.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>1851238</ExpenseAmt>
        <GrantAmt>986154</GrantAmt>
        <RevenueAmt>17643</RevenueAmt>
        <Desc>SEE SCHEDULE O.RESEARCHRESEARCH PROGRAMSSCIENTIFIC STUDY OF THE RELATIONSHIP OF DIET, PHYSICAL ACTIVITY AND WEIGHT MANAGEMENT TO CANCER RISK AND SURVIVORSHIP CONTINUES TO BE THE PRIMARY FOCUS OF AMERICAN INSTITUTE FOR CANCER RESEARCH (AICR) RESEARCH INVESTMENT AND ACTIVITIES. EVIDENCE SHOWS THAT WEIGHT MANAGEMENT, PHYSICAL ACTIVITY, FOOD AND NUTRITION PLAY IMPORTANT ROLES IN CANCER PREVENTION, TREATMENT AND SURVIVORSHIP. RESEARCH SHOWS THAT APPROXIMATELY 40% OF ALL CANCERS COULD BE PREVENTED IF EVERYONE REACHED AND MAINTAINED A HEALTHY WEIGHT, FOLLOWED THE RECOMMENDATIONS FOR REGULAR PHYSICAL ACTIVITY, CONSUMED A HEALTHY DIET, AVOIDED USE OF TOBACCO PRODUCTS AND FOLLOWED APPROPRIATE SCREENING AND VACCINATION GUIDELINES. AICR IS UNIQUE IN ITS FOCUS ON PREVENTING CANCER AND IMPROVING SURVIVAL THROUGH DIET, NUTRITION, BODY COMPOSITION AND PHYSICAL ACTIVITY. WE COLLATE AND INTERPRET THE LATEST AND MOST AUTHORITATIVE GLOBAL SCIENTIFIC RESEARCH ON THE LINKS BETWEEN CANCER AND DIET, NUTRITION, BODY COMPOSITION AND PHYSICAL ACTIVITY. WE THEN TRANSLATE OUR FINDINGS INTO PRACTICAL, CLEAR, EVIDENCE-BASED RECOMMENDATIONS ON CANCER PREVENTION FOR USE BY HEALTH PROFESSIONALS, INDIVIDUALS AND GOVERNMENTS WORLDWIDE.IN TOTAL, THROUGH FY24, AICR HAS COMMITTED MORE THAN $112 MILLION FOR HUNDREDS OF INDIVIDUAL RESEARCH PROJECTS AT UNIVERSITIES, HOSPITALS AND RESEARCH CENTERS.AICR PIONEERED THE FUNDING OF RESEARCH EXAMINING DIET AND CANCER AND WAS THE FIRST ORGANIZATION TO DEVOTE ITSELF TO STUDYING THE ROLE OF DIET AND OTHER LIFESTYLE FACTORS IN LOWERING CANCER RISK. THE RESEARCH THAT WE HAVE FUNDED HAS HELPED TRANSFORM THE ONCE-RADICAL NOTION THAT EVERYDAY CHOICES CAN DRAMATICALLY REDUCE CANCER RISK INTO A UNIVERSALLY ACCEPTED MEDICAL FACT AND PUBLIC HEALTH POLICY.OUR MULTI-FACETED INVESTMENT IN RESEARCH CONTINUES ACROSS SEVERAL CORE ACTIVITIES.AICR GRANT PROGRAMSTHE AICR GRANT PROGRAMS ARE DEDICATED TO FUNDING RESEARCH ON CANCER PREVENTION, TREATMENT AND SURVIVAL RELATED TO DIET, NUTRITION, BODY COMPOSITION AND PHYSICAL ACTIVITY. ALL APPLICATIONS ARE SUBJECTED TO RIGOROUS PEER REVIEW. INSPIRE RESEARCH CHALLENGE: IN 2023, AICR INITIATED A NEW GRANT PROGRAM, THE "INSPIRE RESEARCH CHALLENGE," IN ADDITION TO OUR EXISTING INVESTIGATOR-INITIATED RESEARCH GRANT PROGRAM. THE INSPIRE RESEARCH CHALLENGE IS A PARTNERSHIP WITH THE WORLD CANCER RESEARCH FUND (WCRF) INTERNATIONAL WITH THE GOAL OF SUPPORTING INNOVATIVE IDEAS FROM EARLY CAREER RESEARCHERS WITHIN 2-6 YEARS OF PHD COMPLETION. 2024 SAW THE FUNDING OF THE FIRST ROUND OF APPROVED INSPIRE RESEARCH CHALLENGE GRANTS, AND THE CONTINUATION OF THE PROGRAM. THE 2024 GRANT REVIEW PANEL WAS CHAIRED BY DR. RICHARD SIMPSON (UNIVERSITY OF ARIZONA) AND DR. AMANDA CROSS (IMPERIAL COLLEGE LONDON) WITH WRITTEN REVIEW INLCUDED DR. YIKYUNG PARK (WASHINGTON UNIVERSITY), DR. KATHRYN BECK (MASSEY UNIVERSITY), DR. CHRISTINA DAHM (AARHUS UNIVERSITY), DR. RICHARD SIMPSON (ARIZONA UNIVERSITY), DR. ELLEN KAMPMAN (WAGENINGENUNIVERSITY), AND DR. JAMES TURNER (UNIVERSITY OF BIRMINGHAM). REPORTS PROVIDED FROM EXTERNAL INDEPENDENT CONTENT EXPERTS. INVESTIGATOR-INITIATED RESEARCH GRANT (IIG) PROGRAM: FOR THE 2024 CYCLE OF THE INVESTIGATOR-INITIATED RESEARCH GRANT PROGRAM GRANT CYCLE, WE RECEIVED 125 LETTERS OF INTENT: 47 ON CANCER PREVENTION, 62 ON CANCER SURVIVORSHIP AND 16 COVERING BOTH AREAS. WE INVITED 32 APPLICANTS TO SUBMIT FULL APPLICATIONS AND RECEIVED 27 FOR OUR GRANT PANEL TO REVIEW AND DISCUSS. FOR THE 2024 GRANT CYCLE, WE WELCOMED CO-CHAIRS DR. LINDA COOK (CANCER CENTER ASSOCIATE DIRECTOR FOR POPULATION SCIENCE, TENURED PROFESSOR IN THE DEPARTMENT OF EPIDEMIOLOGY, COLORADO SCHOOL OF PUBLIC HEALTH) AND DR. PAUL SPAGNUOLO (ASSOCIATE PROFESSOR IN THE DEPARTMENT OF FOOD SCIENCE, UNIVERSITY OF GUELPH). THE GRANT REVIEW PANEL INCLUDED 11 ADDITIONAL EXPERTS WITH THE DEPTH AND BREADTH OF EXPERTISE TO EVALUATE THE SCIENTIFIC MERIT AND IMPACT OF THE PROPOSED RESEARCH. THE GRANT REVIEW PANEL MEETING WAS CONDUCTED IN A HYBRID FORMAT WITH THE TWO CO-CHAIRS JOINING US IN-PERSON AND THE OTHER REVIEWERS ATTENDING BY VIDEO CONFERENCE. REVIEWERS- CHRISTINA DIELI-CONWRIGHT, PHD, MPH, DANA-FARBER CANCER INSTITUTE- DANIEL HALL, PHD, MASSACHUSETTS GENERAL HOSPITAL- DONG-WOO KANG, PHD, DANA-FARBER CANCER INSTITUTE- EMILY LAVOY, PHD, UNIVERSITY OF HOUSTON- YUE LIAO, PHD, MPH, CPH, UNIVERSITY OF TEXAS, ARLINGTON- GERARDO MACKENZIE, PHD, UNIVERSITY OF CALIFORNIA, DAVIS- CONNIE ROGERS, PHD, PENNSYLVANIA STATE UNIVERSITY- KERI SCHADLER, PHD, UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER- PATRICIA WOLF, PHD, RDN, PURDUE UNIVERSITYFUNDED GRANTSIIG1.REFINEEMENT AND PROOF-OF-CONCEPT TESTING OF A "FOOD IS MEDICINE" INTERVENTION FOR CHILDHOOD CANCER SURVIVORS. RAHELA AZIZ-BOSE, MD, MPH, DANA-FARBER CANCER INSTITUTE 2. EFFECTS OF GLYCEMIC CONTROL DURING COLON CANCER TREATMENT MEASURED USING CONTINUOUS GLUCOSE MONITORING. JUSTIN BROWN, PHD, LOUISIANA STATE UNIVERSITY3. MECHANISMS RESPONSIBLE FOR THE BENEFICIAL EFFECTS OF RESISTANCE/ENDURANCE EXERCISE TRAINING IN CANCER CACHEXIA, MICHAEL DE LISIO, PHD, UNIVERSITY OF OTTAWA 4. DIGITAL LIFESTYLE INTERVENTION TO IMPROVE NORMAL WEIGHT OBESITY IN PRIMARY BREAST CANCER. NEIL IYENGAR, MD, MEMORIAL SLOAN KETTERING5. A PROBIOTIC APPROACH TO ALTER FARNESOID X RECEPTOR SIGNALING IN IMMUNE CELLS AND THUS TREAT METASTATIC BREAST CANCER. ERIK NELSON, PHD, UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN INSPIRE (FUNDED BY THE WCRF/AICR NETWORK)6. EARLY LIFE INFECTIONS: PATHWAYS TO PREVENT ADULT CANCERS? JULIE AARESTRUP, MS, PHD, BISPEBJERG AND FREDERIKSBERG HOSPITAL, KBENHAVN, DENMARK7. IMPACT OF SLEEP ON THE DEVELOPMENT OF REPRODUCTIVE SYSTEM CANCERS. CHRISTOS CHALITSIOS, PHD, MSC, UNIVERSITY OF IOANNINA, IOANNINA, GREECE8. LIFE-S-CAN: CLINICAL TOOL TO SCREEN AND IMPROVE CANCER SURVIVORSHIP CARE AND QUALITY OF LIFE. ALICE CHAPLIN, PHD, MSC, CONSORCIO CENTRO DE INVESTIGACIN BIOMDICA EN RED, MADRID, SPAIN9. EXPLORING THE MECHANISMS LINKING SLEEP PATTERNS AND BREAST CANCER RISK. SHAN LUO, PHD, MPH, UNIVERSITY OF HONG KONG, POK FU LAM, HONG KONG10. HOW HIGH-INTENSITY EXERCISE AND FIBER AFFECT IMMUNOTHERAPY OUTCOMES FOR PATIENTS WITH MELANOMA. DONG-WOO KANG, PHD, CEP/CET, DANA-FARBER CANCER INSTITUTE, BOSTON, MA11. USING AI CHATBOTS TO SUPPORT FAMILIES OF CHILDREN WITH CANCER. MICAH SKEENS, PHD, APRN, FAAN, RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL, COLUMBUS, OHAICR EXPERT REPORTSSINCE 2007, AICR AND ITS INTERNATIONAL AFFILIATE, THE WORLD CANCER RESEARCH FUND (WCRF), HAVE WORKED TOGETHER ON THE CONTINUOUS UPDATE PROJECT (CUP). THE CUP HAS BUILT ON THE SYSTEMATIC LITERATURE REVIEW CONDUCTED FOR OUR 2007 SECOND EXPERT REPORT FOOD, NUTRITION, PHYSICAL ACTIVITY, AND THE PREVENTION OF CANCER: A GLOBAL PERSPECTIVE. IN 2018, AICR AND WCRF PUBLISHED DIET, NUTRITION, PHYSICAL ACTIVITY AND CANCER: A GLOBAL PERSPECTIVE, THE THIRD EXPERT REPORT TO UPDATE BOTH THE ASSESSMENT OF THE EVIDENCE FOR THE IMPACT OF EACH FACTOR ON CANCER RISK AND REVISE THE CANCER PREVENTION RECOMMENDATIONS THE CUP PROVIDES THROUGH TIMELY REVIEWS AND EXPERT PANEL ASSESSMENTS OF THE AVAILABLE PEER-REVIEWED EVIDENCE. THE CUP REPORTS HAVE IDENTIFIED EMERGING RESEARCH AREAS AND KNOWLEDGE GAPS THAT COULD BE ADDRESSED WITHIN OUR GRANT PROGRAM. EQUALLY, NEW DATA GENERATED FROM STUDIES FUNDED THROUGH OUR GRANT PROGRAM ARE INCLUDED IN THE CUP REVIEWS. THUS, AICR'S RESEARCH GRANT PROGRAMS AND THE CUP ACT SYNERGISTICALLY TO STRENGTHEN THE SCIENTIFIC EVIDENCE ON THE IMPACT OF DIET, NUTRITION, BODY COMPOSITION AND PHYSICAL ACTIVITY ON CANCER PREVENTION AND CONTROL.IN 2020, THE CUP EMBARKED ON A PROCESS OF EVALUATION AND STRATEGIC PLANNING, TERMED THE CUP TRANSITION, WITH A PANEL OF INTERNATIONAL EXPERTS TO DETERMINE THE OPTIMAL DIRECTIONS FOR FUTURE RESEARCH IN THIS FIELD. THIS PROCESS CONTINUED THROUGH 2021, CONCLUDING WITH THE DEVELOPMENT OF A NEW STRATEGY THAT WAS OPERATIONALIZED IN 2022. CONCURRENTLY, THE CUP TRANSITION PANEL REVIEWED THE COMPLETED SYSTEMATIC LITERATURE REVIEWS ON MEDICAL OUTCOMES AND QUALITY OF LIFE IN BREAST CANCER SURVIVORS AND SUBMITTED SEVERAL MANUSCRIPTS FOR PUBLICATION IN PEER-REVIEWED JOURNALS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <TotalProgramServiceExpensesAmt>6544583</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">1</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">1</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc1041200001">1</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc1041200001">0</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc1041200001">0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc1042800001">0</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc1042800001">0</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc1042800001">0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>1</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>1</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="RetDoc1043400001">1</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <InfoInScheduleOPartVInd>X</InfoInScheduleOPartVInd>
      <IRPDocumentCnt>25</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>41</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>1</ForeignFinancialAccountInd>
      <ForeignCountryCd>UK</ForeignCountryCd>
      <ForeignCountryCd>NL</ForeignCountryCd>
      <ForeignCountryCd>HK</ForeignCountryCd>
      <ForeignCountryCd>FR</ForeignCountryCd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>5</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>5</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>AL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>GA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>HI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NM</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WV</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>JENNIFER MERCER</PersonNm>
        <PhoneNum>2023287744</PhoneNum>
        <USAddress>
          <AddressLine1Txt>1560 WILSON BOULEVARD 425</AddressLine1Txt>
          <CityNm>ARLINGTON</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22209</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARILYN GENTRY</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>3.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELVIN HUTSON</PersonNm>
        <TitleTxt>BOARD CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SUSAN PEPPER</PersonNm>
        <TitleTxt>BOARD SEC./TREASURER (THRU 09/28/24)</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FRANK JACKSON HILL</PersonNm>
        <TitleTxt>BOARD TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN MCCALLA</PersonNm>
        <TitleTxt>BOARD SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GEOFFREY HERALD</PersonNm>
        <TitleTxt>BOARD MEMBER (THRU 07/03/24)</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOSEPH SWARTZ</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEIRDRE MCGINLEY-GIESER</PersonNm>
        <TitleTxt>EXECUTIVE VP (THRU 12/29/23)</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>176167</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>29755</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JENNIFER MERCER</PersonNm>
        <TitleTxt>SENIOR VP DEVELOPMENT</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>174399</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>35379</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NIGEL BROCKTON</PersonNm>
        <TitleTxt>VP RESEARCH</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>146530</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>39394</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL MCCARN</PersonNm>
        <TitleTxt>CHIEF INFORMATION OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>146606</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>39143</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JERNELL ALEXANDER</PersonNm>
        <TitleTxt>SR. DIR. FINANCE &amp; OPS (THRU 04/30/24)</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>142040</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14784</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELISSA HABEDANK</PersonNm>
        <TitleTxt>VP EXT. RELATIONS (THRU 01/31/24)</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>128094</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>913836</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>158455</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>9</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>PRINT MAIL COMMUNICATIONS INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>4333 DAVENPORT ROAD</AddressLine1Txt>
            <CityNm>FREDERICKSBURG</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22408</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DIRECT MAIL SOLUTIONS</ServicesDesc>
        <CompensationAmt>1171698</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>SOUTHWEST PUBLISHING &amp; MAILING CORP</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>4000 SE ADAMS STREET</AddressLine1Txt>
            <CityNm>TOPEKA</CityNm>
            <StateAbbreviationCd>KS</StateAbbreviationCd>
            <ZIPCd>66609</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MAILHOUSE CONSULTANT</ServicesDesc>
        <CompensationAmt>858164</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>THE DATA CENTER INC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>9720 CAPITAL COURT SUITE 101</AddressLine1Txt>
            <CityNm>MANASSAS</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>20110</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DATA PROCESSING FEES</ServicesDesc>
        <CompensationAmt>686407</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>DIRECT RESPONSE CONSULTING SERVICES</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>7918 JONES BRANCH DRIVE</AddressLine1Txt>
            <CityNm>MCLEAN</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22102</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>FUNDRAISING CONSULTANT</ServicesDesc>
        <CompensationAmt>255765</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>MOORE RESPONSE SERVICES</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>100 JAMISON COURT</AddressLine1Txt>
            <CityNm>HAGERSTOWN</CityNm>
            <StateAbbreviationCd>MD</StateAbbreviationCd>
            <ZIPCd>21740</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DIRECT MAIL SOLUTIONS</ServicesDesc>
        <CompensationAmt>189875</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>10</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>8592095</AllOtherContributionsAmt>
      <TotalContributionsAmt>8592095</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>SERVICE FEES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1263074</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1263074</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>BROCHURE SALES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>17643</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>17643</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>1280717</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>321671</TotalRevenueColumnAmt>
        <ExclusionAmt>321671</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>3178758</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>2606948</SecuritiesAmt>
        <OtherAmt>200583</OtherAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>571810</SecuritiesAmt>
        <OtherAmt>-200583</OtherAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>371227</TotalRevenueColumnAmt>
        <ExclusionAmt>371227</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <OtherRevenueMiscGrp>
        <Desc>MAILING LIST RENTAL</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>139367</TotalRevenueColumnAmt>
        <ExclusionAmt>139367</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>4313</TotalRevenueColumnAmt>
        <ExclusionAmt>4313</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>143680</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>10709390</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1280717</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>836578</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>659886</TotalAmt>
        <ProgramServicesAmt>659886</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>733312</TotalAmt>
        <ProgramServicesAmt>733312</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>200437</TotalAmt>
        <ProgramServicesAmt>200437</ProgramServicesAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>1904335</TotalAmt>
        <ProgramServicesAmt>963411</ProgramServicesAmt>
        <ManagementAndGeneralAmt>731603</ManagementAndGeneralAmt>
        <FundraisingAmt>209321</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>42078</TotalAmt>
        <ProgramServicesAmt>8605</ProgramServicesAmt>
        <ManagementAndGeneralAmt>26160</ManagementAndGeneralAmt>
        <FundraisingAmt>7313</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>224559</TotalAmt>
        <ProgramServicesAmt>102047</ProgramServicesAmt>
        <ManagementAndGeneralAmt>90063</ManagementAndGeneralAmt>
        <FundraisingAmt>32449</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>165478</TotalAmt>
        <ProgramServicesAmt>84004</ProgramServicesAmt>
        <ManagementAndGeneralAmt>59894</ManagementAndGeneralAmt>
        <FundraisingAmt>21580</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>44356</TotalAmt>
        <ProgramServicesAmt>24373</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8863</ManagementAndGeneralAmt>
        <FundraisingAmt>11120</FundraisingAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>32875</TotalAmt>
        <ProgramServicesAmt>18718</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9817</ManagementAndGeneralAmt>
        <FundraisingAmt>4340</FundraisingAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>484998</TotalAmt>
        <FundraisingAmt>484998</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>41000</TotalAmt>
        <ManagementAndGeneralAmt>41000</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>695836</TotalAmt>
        <ProgramServicesAmt>512490</ProgramServicesAmt>
        <ManagementAndGeneralAmt>183346</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>181127</TotalAmt>
        <ProgramServicesAmt>93570</ProgramServicesAmt>
        <ManagementAndGeneralAmt>46080</ManagementAndGeneralAmt>
        <FundraisingAmt>41477</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>92504</TotalAmt>
        <ProgramServicesAmt>59967</ProgramServicesAmt>
        <ManagementAndGeneralAmt>27091</ManagementAndGeneralAmt>
        <FundraisingAmt>5446</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>260573</TotalAmt>
        <ProgramServicesAmt>148361</ProgramServicesAmt>
        <ManagementAndGeneralAmt>77814</ManagementAndGeneralAmt>
        <FundraisingAmt>34398</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>63565</TotalAmt>
        <ProgramServicesAmt>28619</ProgramServicesAmt>
        <ManagementAndGeneralAmt>30021</ManagementAndGeneralAmt>
        <FundraisingAmt>4925</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>3563</TotalAmt>
        <ProgramServicesAmt>3330</ProgramServicesAmt>
        <ManagementAndGeneralAmt>70</ManagementAndGeneralAmt>
        <FundraisingAmt>163</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>42636</TotalAmt>
        <ManagementAndGeneralAmt>42636</ManagementAndGeneralAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>61099</TotalAmt>
        <ProgramServicesAmt>61099</ProgramServicesAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>36485</TotalAmt>
        <ProgramServicesAmt>20797</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10945</ManagementAndGeneralAmt>
        <FundraisingAmt>4743</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>20891</TotalAmt>
        <ProgramServicesAmt>10797</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7042</ManagementAndGeneralAmt>
        <FundraisingAmt>3052</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>POSTAGE &amp; DELIVERY</Desc>
        <TotalAmt>1818553</TotalAmt>
        <ProgramServicesAmt>1078513</ProgramServicesAmt>
        <ManagementAndGeneralAmt>41977</ManagementAndGeneralAmt>
        <FundraisingAmt>698063</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PRINTING &amp; PUBLICATION</Desc>
        <TotalAmt>1359992</TotalAmt>
        <ProgramServicesAmt>850435</ProgramServicesAmt>
        <ManagementAndGeneralAmt>67816</ManagementAndGeneralAmt>
        <FundraisingAmt>441741</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DATA PROCESSING</Desc>
        <TotalAmt>807817</TotalAmt>
        <ProgramServicesAmt>383300</ProgramServicesAmt>
        <ManagementAndGeneralAmt>180728</ManagementAndGeneralAmt>
        <FundraisingAmt>243789</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MAILHOUSE FEES</Desc>
        <TotalAmt>273551</TotalAmt>
        <ProgramServicesAmt>267144</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6407</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>313383</TotalAmt>
        <ProgramServicesAmt>231368</ProgramServicesAmt>
        <ManagementAndGeneralAmt>22832</ManagementAndGeneralAmt>
        <FundraisingAmt>59183</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>10564889</TotalAmt>
        <ProgramServicesAmt>6544583</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1712205</ManagementAndGeneralAmt>
        <FundraisingAmt>2308101</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <JointCostsInd>X</JointCostsInd>
      <TotalJointCostsGrp>
        <TotalAmt>3221219</TotalAmt>
        <ProgramServicesAmt>1972633</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1002</ManagementAndGeneralAmt>
        <FundraisingAmt>1247584</FundraisingAmt>
      </TotalJointCostsGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>10934</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>4248954</BOYAmt>
        <EOYAmt>3329472</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>2116604</BOYAmt>
        <EOYAmt>2084946</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>76389</BOYAmt>
        <EOYAmt>104695</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>274121</BOYAmt>
        <EOYAmt>276476</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>396500</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>364373</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>250569</BOYAmt>
        <EOYAmt>32127</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>1416722</BOYAmt>
        <EOYAmt>2669918</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>7205618</BOYAmt>
        <EOYAmt>7944621</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>2318438</BOYAmt>
        <EOYAmt>1477462</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>17918349</BOYAmt>
        <EOYAmt>17919717</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>600621</BOYAmt>
        <EOYAmt>693970</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>1856246</BOYAmt>
        <EOYAmt>1698011</EOYAmt>
      </GrantsPayableGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>3218880</BOYAmt>
        <EOYAmt>2223533</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>5675747</BOYAmt>
        <EOYAmt>4615514</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>4316897</BOYAmt>
        <EOYAmt>5072350</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>7925705</BOYAmt>
        <EOYAmt>8231853</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>12242602</BOYAmt>
        <EOYAmt>13304203</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>17918349</BOYAmt>
        <EOYAmt>17919717</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>144501</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>874327</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>42773</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>12226058</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>10837807</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12273935</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>10094745</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>8592095</CurrentTaxYearAmt>
        <TotalAmt>54024640</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>12226058</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>10837807</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>12273935</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>10094745</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>8592095</CurrentTaxYearAmt>
        <TotalAmt>54024640</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>2757517</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>51267123</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>240918</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>208468</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>275814</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>237474</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>321671</CurrentTaxYearAmt>
        <TotalAmt>1284345</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>253743</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1555351</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>203990</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>155338</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>143680</CurrentTaxYearAmt>
        <TotalAmt>2312102</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>57621087</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>6377367</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.88970</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.86220</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER INCOME - 2019 AMOUNT: $ 253,743. 2020 AMOUNT: $ 1,555,351. 2021 AMOUNT: $ 203,990. 2022 AMOUNT: $ 155,338. 2023 AMOUNT: $ 143,680.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>2190339</BeginningYearBalanceAmt>
        <ContributionsAmt>31525</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>524382</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>0</GrantsOrScholarshipsAmt>
        <OtherExpendituresAmt>196894</OtherExpendituresAmt>
        <AdministrativeExpensesAmt>0</AdministrativeExpensesAmt>
        <EndYearBalanceAmt>2549352</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2084888</BeginningYearBalanceAmt>
        <ContributionsAmt>18145</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>261636</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>174330</OtherExpendituresAmt>
        <EndYearBalanceAmt>2190339</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2504791</BeginningYearBalanceAmt>
        <ContributionsAmt>290307</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-537422</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>172788</OtherExpendituresAmt>
        <EndYearBalanceAmt>2084888</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2045005</BeginningYearBalanceAmt>
        <ContributionsAmt>297100</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>367867</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>205181</OtherExpendituresAmt>
        <EndYearBalanceAmt>2504791</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>2123034</BeginningYearBalanceAmt>
        <ContributionsAmt>3365</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>242611</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>324005</OtherExpendituresAmt>
        <EndYearBalanceAmt>2045005</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.16000</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.30000</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.54000</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>5900</OtherCostOrOtherBasisAmt>
        <BookValueAmt>5900</BookValueAmt>
      </LandGrp>
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>3625</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>173</DepreciationAmt>
        <BookValueAmt>3452</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>312317</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>298732</DepreciationAmt>
        <BookValueAmt>13585</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>74658</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>65468</DepreciationAmt>
        <BookValueAmt>9190</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>32127</TotalBookValueLandBuildingsAmt>
      <InvstProgramRelatedOrgGrp>
        <Desc>CHARITABLE GIFT ANNUITIES</Desc>
        <BookValueAmt>1207758</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </InvstProgramRelatedOrgGrp>
      <InvstProgramRelatedOrgGrp>
        <Desc>CHARITABLE REMAINDER UNITRUSTS</Desc>
        <BookValueAmt>874545</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </InvstProgramRelatedOrgGrp>
      <InvstProgramRelatedOrgGrp>
        <Desc>CANCER RESEARCH FUND</Desc>
        <BookValueAmt>5862318</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </InvstProgramRelatedOrgGrp>
      <TotalBookValueProgramRltdAmt>7944621</TotalBookValueProgramRltdAmt>
      <OtherAssetsOrgGrp>
        <Desc>BENEFICIAL INT. IN PERPETUAL TRUST</Desc>
        <BookValueAmt>371329</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>DUE FROM AFFILIATES</Desc>
        <BookValueAmt>469843</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>RIGHT OF USE ASSETS</Desc>
        <BookValueAmt>636290</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>1477462</TotalBookValueOtherAssetsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>LIABILITY CHARITABLE GIFT ANNUITIES</Desc>
        <Amt>719040</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>LIABILITY CHARITABLE REMAINDER</Desc>
        <Amt>359942</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>RIGHT OF USE LIABILITIES</Desc>
        <Amt>644551</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>DEFERRED RENT</Desc>
        <Amt>500000</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>2223533</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>11615435</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>874327</NetUnrealizedGainsInvstAmt>
      <OtherRevenueAmt>72718</OtherRevenueAmt>
      <RevenueNotReportedAmt>947045</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>10668390</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>41000</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>41000</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>10709390</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>10523889</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>10523889</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>41000</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>41000</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>10564889</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S ENDOWMENT FUNDS ARE ESTABLISHED TO FURTHER THE MISSION OF THE AMERICAN INSTITUTE FOR CANCER RESEARCH. THE PERSON ESTABLISHING THE FUND DESIGNATED THE PURPOSE OF THEIR FUND, (I.E., CANCER RESEARCH, EDUCATION OR GENERAL OPERATING).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INSTITUTE IS RECOGNIZED AS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ON INCOME OTHER THAN UNRELATED BUSINESS INCOME. NO PROVISION FOR INCOME TAXES IS REQUIRED AS OF SEPTEMBER 30, 2024 AND 2023, SINCE THE INSTITUTE HAD NO UNRELATED BUSINESS INCOME. THE INSTITUTE HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS A PUBLICLY SUPPORTED ORGANIZATION AND IS THEREFORE NOT A PRIVATE FOUNDATION. MANAGEMENT ANNUALLY REVIEWS ITS TAX POSITION AND HAS DETERMINED THAT THERE ARE NO UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART XI, LINE 2D - OTHER ADJUSTMENTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT LIABILITY - ANNUITIES -21,512. LOSS ON FOREIGN EXCHANGE TRANSACTIONS -22,757. NET GAIN ON INTEREST IN PERPETUAL TRUST 116,987.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTMAKING</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>733312</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>733312</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>733312</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>326268</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>EUROPE (INCLUDING ICELAND &amp; GREENLAND)</RegionTxt>
        <PurposeOfGrantTxt>EDUCATION</PurposeOfGrantTxt>
        <CashGrantAmt>407044</CashGrantAmt>
        <MannerOfCashDisbursementTxt>WIRE</MannerOfCashDisbursementTxt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>1</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>AT THE END OF THE FIRST YEAR OF ANY TWO-YEAR GRANT, THE PRINCIPAL INVESTIGATOR MUST SUBMIT A PROGRESS REPORT, INCLUDING ABSTRACTS AND PUBLICATIONS OF RESEARCH SUPPORTED IN WHOLE OR IN PART BY AICR. AT THE DISCRETION OF AICR, FUNDS FOR THE SECOND YEAR OF THE GRANT MAY BE WITHHELD BASED ON THE PROGRESS REPORT OR IF PROGRESS REPORTS ARE NOT SUBMITTED. FINAL SCIENTIFIC REPORT: WITHIN THREE MONTHS OF THE COMPLETION OF THE GRANT PERIOD, AICR REQUIRES A FINAL COMPREHENSIVE REPORT TO OUTLINE THE PROJECT'S ACCOMPLISHMENTS. FAILURE TO SUBMIT A FINAL REPORT WILL RESULT IN AUTOMATIC DISQUALIFICATION FROM SUBMITTING A GRANT APPLICATION TO AICR FOR TWO YEARS. FINAL FINANCIAL REPORT: A FINAL REPORT OF EXPENDITURES MUST BE SUBMITTED WITHIN THREE MONTHS OF THE TERMINATION OF THE GRANT, TOGETHER WITH THE REFUND OF ANY UNSPENT FUNDS. UNSPENT FUNDS FROM AN EXISTING GRANT MAY ONLY BE CARRIED FORWARD AS A NO-COST EXTENSION TO THE GRANT TERM WITH THE WRITTEN PERMISSION OF AICR. BEFORE GRANT RECOMMENDATIONS ARE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL, ALL APPLICANTS ARE CHECKED AND CLEARED AGAINST THE FOLLOWING TERRORIST WATCH LISTS: SPECIALLY DESIGNATED NATIONALS (SDN), STATE DEPARTMENT TERRORIST EXCLUSIONS LIST, UNITED NATIONS CONSOLIDATED LIST WITH RESPECT TO AL-QAEDA, THE TALIBAN, AND THE EUROPEAN UNION TERRORIST LIST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3:</FormAndLineReferenceDesc>
        <ExplanationTxt>GRANTMAKING EXPENDITURES ARE RECORDED ON THE ACCRUAL BASIS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="RetDoc1041200001">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <PhoneSolicitationsInd>X</PhoneSolicitationsInd>
      <InPersonSolicitationsInd>X</InPersonSolicitationsInd>
      <AgrmtProfFundraisingActyInd>1</AgrmtProfFundraisingActyInd>
      <FundraiserActivityInfoGrp>
        <OrganizationBusinessName>
          <BusinessNameLine1Txt>DIRECT RESPONSE CONSULTING</BusinessNameLine1Txt>
        </OrganizationBusinessName>
        <USAddress>
          <AddressLine1Txt>7918 JONES BRANCH DRIVE</AddressLine1Txt>
          <CityNm>MCLEAN</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22102</ZIPCd>
        </USAddress>
        <ActivityTxt>DIRECT MAIL</ActivityTxt>
        <FundraiserControlOfFundsInd>0</FundraiserControlOfFundsInd>
        <GrossReceiptsAmt>3151455</GrossReceiptsAmt>
        <RetainedByContractorAmt>245724</RetainedByContractorAmt>
        <NetToOrganizationAmt>2905731</NetToOrganizationAmt>
      </FundraiserActivityInfoGrp>
      <FundraiserActivityInfoGrp>
        <OrganizationBusinessName>
          <BusinessNameLine1Txt>INFOCISION MANAGEMENT CORP</BusinessNameLine1Txt>
        </OrganizationBusinessName>
        <USAddress>
          <AddressLine1Txt>325 SPRINGSIDE DR</AddressLine1Txt>
          <CityNm>AKRON</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>44144</ZIPCd>
        </USAddress>
        <ActivityTxt>PHONE</ActivityTxt>
        <FundraiserControlOfFundsInd>0</FundraiserControlOfFundsInd>
        <GrossReceiptsAmt>53950</GrossReceiptsAmt>
        <RetainedByContractorAmt>239274</RetainedByContractorAmt>
        <NetToOrganizationAmt>-185324</NetToOrganizationAmt>
      </FundraiserActivityInfoGrp>
      <TotalGrossReceiptsAmt>3205405</TotalGrossReceiptsAmt>
      <TotalRetainedByContractorsAmt>484998</TotalRetainedByContractorsAmt>
      <TotalNetToOrganizationAmt>2720407</TotalNetToOrganizationAmt>
      <LicensedStatesCd>AL</LicensedStatesCd>
      <LicensedStatesCd>AK</LicensedStatesCd>
      <LicensedStatesCd>AZ</LicensedStatesCd>
      <LicensedStatesCd>AR</LicensedStatesCd>
      <LicensedStatesCd>CA</LicensedStatesCd>
      <LicensedStatesCd>CO</LicensedStatesCd>
      <LicensedStatesCd>CT</LicensedStatesCd>
      <LicensedStatesCd>DE</LicensedStatesCd>
      <LicensedStatesCd>FL</LicensedStatesCd>
      <LicensedStatesCd>GA</LicensedStatesCd>
      <LicensedStatesCd>HI</LicensedStatesCd>
      <LicensedStatesCd>ID</LicensedStatesCd>
      <LicensedStatesCd>IL</LicensedStatesCd>
      <LicensedStatesCd>IN</LicensedStatesCd>
      <LicensedStatesCd>IA</LicensedStatesCd>
      <LicensedStatesCd>KS</LicensedStatesCd>
      <LicensedStatesCd>KY</LicensedStatesCd>
      <LicensedStatesCd>LA</LicensedStatesCd>
      <LicensedStatesCd>ME</LicensedStatesCd>
      <LicensedStatesCd>MD</LicensedStatesCd>
      <LicensedStatesCd>MA</LicensedStatesCd>
      <LicensedStatesCd>MI</LicensedStatesCd>
      <LicensedStatesCd>MN</LicensedStatesCd>
      <LicensedStatesCd>MS</LicensedStatesCd>
      <LicensedStatesCd>MO</LicensedStatesCd>
      <LicensedStatesCd>MT</LicensedStatesCd>
      <LicensedStatesCd>NE</LicensedStatesCd>
      <LicensedStatesCd>NV</LicensedStatesCd>
      <LicensedStatesCd>NH</LicensedStatesCd>
      <LicensedStatesCd>NJ</LicensedStatesCd>
      <LicensedStatesCd>NM</LicensedStatesCd>
      <LicensedStatesCd>NY</LicensedStatesCd>
      <LicensedStatesCd>NC</LicensedStatesCd>
      <LicensedStatesCd>ND</LicensedStatesCd>
      <LicensedStatesCd>OH</LicensedStatesCd>
      <LicensedStatesCd>OK</LicensedStatesCd>
      <LicensedStatesCd>OR</LicensedStatesCd>
      <LicensedStatesCd>PA</LicensedStatesCd>
      <LicensedStatesCd>RI</LicensedStatesCd>
      <LicensedStatesCd>SC</LicensedStatesCd>
      <LicensedStatesCd>SD</LicensedStatesCd>
      <LicensedStatesCd>TN</LicensedStatesCd>
      <LicensedStatesCd>TX</LicensedStatesCd>
      <LicensedStatesCd>UT</LicensedStatesCd>
      <LicensedStatesCd>VT</LicensedStatesCd>
      <LicensedStatesCd>VA</LicensedStatesCd>
      <LicensedStatesCd>WA</LicensedStatesCd>
      <LicensedStatesCd>WV</LicensedStatesCd>
      <LicensedStatesCd>WI</LicensedStatesCd>
      <LicensedStatesCd>WY</LicensedStatesCd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE G, PART I:</FormAndLineReferenceDesc>
        <ExplanationTxt>PAYMENTS TO INFOCISION MANAGEMENT CORPORATION INCLUDE FEES FOR PROFESSIONAL FUNDRAISING SERVICES PLUS FUNDRAISING EXPENSES - LIST DEVELOPMENT, DATA PROCESSING, PRINTING AND MAILHOUSE FEES. INVOICES CLEARLY DISTINGUISH FUNDRAISING FEES FROM FUNDRAISING EXPENSES. ADDITIONAL COSTS, SUCH AS CAGING, BANK CHARGES, OTHER DATA PROCESSING AND POSTAGE ASSOCIATED WITH PHONE SOLICITATIONS ARE PAID DIRECTLY TO THE VENDOR AND THEREFORE NOT INCLUDED IN SCHEDULE G, COLUMN (V) AMOUNTS. PAYMENTS TO DIRECT RESPONSE CONSULTING SERVICES ARE FOR PROFESSIONAL FUNDRAISING SERVICES ONLY. ALL OTHER FUNDRAISING EXPENSES ASSOCIATED WITH DIRECT MAIL FUNDRAISING ARE PAID DIRECTLY TO THE VENDOR PROVIDING THE SERVICE AND THEREFORE NOT INCLUDED IN SCHEDULE G, COLUMN (V) AMOUNTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>DANA-FARBER CANCER INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>450 BROOKLINE AVENUE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02215</ZIPCd>
        </USAddress>
        <RecipientEIN>042263040</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>82500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MEMORIAL SLOAN KETTERING CANCER CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1133 NEW YORK AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10065</ZIPCd>
        </USAddress>
        <RecipientEIN>131624082</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>247500</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PENNINGTON BIOMEDICAL RESEARCH CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6400 PERKINS ROAD</AddressLine1Txt>
          <CityNm>BATON ROUGE</CityNm>
          <StateAbbreviationCd>LA</StateAbbreviationCd>
          <ZIPCd>70808</ZIPCd>
        </USAddress>
        <RecipientEIN>581767810</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>164886</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>901 W ILLINOIS STREET</AddressLine1Txt>
          <CityNm>URBANA</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>61801</ZIPCd>
        </USAddress>
        <RecipientEIN>376000051</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>165000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>4</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>PROGRESS REPORT: AT THE END OF THE FIRST YEAR OF ANY TWO-YEAR GRANT, THE PRINCIPAL INVESTIGATOR MUST SUBMIT A PROGRESS REPORT, INCLUDING ABSTRACTS AND PUBLICATIONS OF RESEARCH SUPPORTED IN WHOLE OR IN PART BY AICR. AT THE DISCRETION OF AICR, FUNDS FOR THE SECOND YEAR OF THE GRANT MAY BE WITHHELD BASED ON THE PROGRESS REPORT OR IF PROGRESS REPORTS ARE NOT SUBMITTED. FINAL SCIENTIFIC REPORT: WITHIN THREE MONTHS OF THE COMPLETION OF THE GRANT PERIOD, AICR REQUIRES A FINAL COMPREHENSIVE REPORT TO OUTLINE THE PROJECT'S ACCOMPLISHMENTS. FAILURE TO SUBMIT A FINAL REPORT WILL RESULT IN AUTOMATIC DISQUALIFICATION FROM SUBMITTING A GRANT APPLICATION TO AICR FOR TWO YEARS. FINAL FINANCIAL REPORT: A FINAL REPORT OF EXPENDITURES MUST BE SUBMITTED WITHIN THREE MONTHS OF THE TERMINATION OF THE GRANT, TOGETHER WITH THE REFUND OF ANY UNSPENT FUNDS. UNSPENT FUNDS FROM AN EXISTING GRANT MAY ONLY BE CARRIED FORWARD AS A NO-COST EXTENSION TO THE GRANT TERM WITH THE WRITTEN PERMISSION OF AICR. BEFORE GRANT RECOMMENDATIONS ARE PRESENTED TO THE BOARD OF DIRECTORS FOR APPROVAL, ALL APPLICANTS ARE CHECKED AND CLEARED AGAINST THE FOLLOWING TERRORIST WATCH LISTS: SPECIALLY DESIGNATED NATIONALS (SDN), STATE DEPARTMENT TERRORIST EXCLUSIONS LIST, UNITED NATIONS CONSOLIDATED LIST WITH RESPECT TO AL-QAEDA, THE TALIBAN, AND THE EUROPEAN UNION TERRORIST LIST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JENNIFER MERCER</PersonNm>
        <TitleTxt>SENIOR VP DEVELOPMENT</TitleTxt>
        <BaseCompensationFilingOrgAmt>174160</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>239</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5485</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>29894</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>209778</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DEIRDRE MCGINLEY-GIESER</PersonNm>
        <TitleTxt>EXECUTIVE VP (THRU 12/29/23)</TitleTxt>
        <BaseCompensationFilingOrgAmt>175115</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1052</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>5485</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>24270</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>205922</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>NIGEL BROCKTON</PersonNm>
        <TitleTxt>VP RESEARCH</TitleTxt>
        <BaseCompensationFilingOrgAmt>146236</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>294</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>4703</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>34691</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>185924</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MICHAEL MCCARN</PersonNm>
        <TitleTxt>CHIEF INFORMATION OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>145026</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1580</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>4612</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>34531</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>185749</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JERNELL ALEXANDER</PersonNm>
        <TitleTxt>SR. DIR. FINANCE &amp; OPS (THRU 04/30/2</TitleTxt>
        <BaseCompensationFilingOrgAmt>141786</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>254</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>14784</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>156824</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <BusinessName>
            <BusinessNameLine1Txt>DIRECT RESPONSE CONSULTING SERVICES</BusinessNameLine1Txt>
          </BusinessName>
        </NameOfInterested>
        <RelationshipDescriptionTxt>100% CONTROLLED ENTITY OF ONE OF THE FOUNDERS OF AICR</RelationshipDescriptionTxt>
        <TransactionAmt>245724</TransactionAmt>
        <TransactionDesc>FUNDRAISING CONSULTANT</TransactionDesc>
        <SharingOfRevenuesInd>0</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4A, CONTINUED.</FormAndLineReferenceDesc>
        <ExplanationTxt>CANCER HEALTH CHECK AN ONLINE ASSESSMENT TOOL TO HELP INDIVIDUALS UNDERSTAND HOW THE LIFESTYLE CHOICES THEY MAKE EVERY DAY CAN REDUCE THEIR RISK FOR CANCER. THIS SIMPLE AND EASY TOOL MEASURES INDIVIDUAL LIFESTYLE CHOICES, LIKE DIET AND EXERCISE HABITS, AGAINST AICR'S EVIDENCE-BASED 10 CANCER PREVENTION RECOMMENDATIONS. AFTER USERS ANSWER A BRIEF SERIES OF QUESTIONS, THEY IMMEDIATELY RECEIVE A SUMMARY OF RESULTS THAT SHOW AREAS WHERE THEY ARE DOING WELL AND WHERE THERE ARE AREAS FOR IMPROVEMENT. THIS IS AN APPROACHABLE TOOL THAT IS USED BY BOTH THE GENERAL PUBLIC AND BY HEALTH-CARE PROVIDERS. THIS INNOVATIVE TOOL LAUNCHED IN FEBRUARY 2020 WAS AWARDED GOLD/FIRST PLACE IN THE DIGITAL HEALTH RESOURCES/TOOL CATEGORY IN THE 2020 FALL DIGITAL HEALTH AWARDS. THERE WAS A TOTAL OF 4,613 USERS/E-MAILS COLLECTED IN FY2024 LIVING WITH CANCER AND BEYOND: CANCER RESOURCE PROGRAM AICR OFFERS A FREE BOOKLET OF ADVICE FOR NEWLY DIAGNOSED CANCER PATIENTS AND THEIR LOVED ONES. DEVELOPED WITH A TEAM OF PHYSICIANS, NURSES, DIETITIANS, PSYCHOLOGISTS AND CANCER PATIENTS, CANCER RESOURCE LAYS OUT INFORMATION PATIENTS NEED, INCLUDING QUESTIONS TO ASK YOUR DOCTOR, TREATMENT OPTIONS, WHERE TO FIND HELP, NUTRITION DURING TREATMENT AND MUCH MORE. AICR STAFF CAN CREATE CUSTOMIZED PACKETS FOR ANY CANCER BY INCLUDING SPECIFIC, DETAILED AND UP-TO-DATE PRINTOUTS ABOUT THE RELEVANT CANCER. REQUESTS FOR EACH PACKET ARE FILLED IMMEDIATELY TO GET THIS VITAL INFORMATION TO THOSE WHO NEED IT AS QUICKLY AS POSSIBLE. CANCER RESOURCE IS ALSO AVAILABLE IN SPANISH, WHICH INCREASES ACCESS TO THIS INFORMATION EVEN FURTHER AS A FREE DOWNLOADABLE ON AICR'S ONLINE STORE. IN FY24 THERE WERE A TOTAL OF 123 CANCER RESOURCE BOOKS SOLD. AICR'S HEALTH PROFESSIONAL AND EDUCATOR COMMUNITY AICR'S HP COMMUNITY PROVIDES AN ONLINE DESTINATION FOR HEALTH PROFESSIONALS, FEATURING A WEALTH OF INTERACTIVE TOOLS, CONTINUING EDUCATION OPPORTUNITIES AND PRACTICAL EVIDENCE-BASED RESOURCES FOR PATIENTS AND CLIENTS. PROGRAMS FOR CANCER SURVIVORS THE OVERALL AGING OF THE UNITED STATES POPULATION AND CHANGING PREVALENCE OF RISK FACTORS, INCLUDING OBESITY, HAVE INCREASED THE INCIDENCE OF MANY TYPES OF CANCER WHILE ADVANCES IN THE EARLY DETECTION AND TREATMENT OF CANCER HAVE LED TO REDUCED CANCER MORTALITY. THESE FACTORS HAVE COMBINED TO DRAMATICALLY INCREASE THE NUMBER OF CANCER SURVIVORS. NEARLY 18.3 MILLION PEOPLE IN THE US WERE LIVING WITH A HISTORY OF A CANCER DIAGNOSIS AS OF JANUARY 2022. THIS NUMBER IS PROJECTED TO GROW TO MORE THAN 26 MILLION BY 2040. DURING FY24, AICR PROACTIVELY FUNDED RESEARCH, DEVELOPED EVIDENCE-BASED INFORMATION AND CONTRIBUTED TOOLS, RESOURCES AND PROGRAMS THAT ARE ATTUNED TO THIS GROWING POPULATION. CONFERENCES AND EXHIBITS IN FY24, AICR STAFF ATTENDED, PRESENTED, NETWORKED, EXHIBITED AND/OR DISTRIBUTED MATERIALS AT VARIOUS IN-PERSON AND VIRTUAL CONFERENCES AND ANNUAL MEETINGS. EXTERNAL RELATIONS IN FY24, AICR BUILT DEEPER RELATIONSHIPS WITH KEY NATIONAL, REGIONAL AND LOCAL STAKEHOLDER ORGANIZATIONS TO LEVERAGE THESE PARTNERSHIPS AND ENSURE OUR EVIDENCE-BASED MESSAGES AND EDUCATIONAL RESOURCES ARE UNDERSTOOD AND UTILIZED. AICR PROACTIVELY JOINED ADDITIONAL ORGANIZATIONS' COMMITTEES AND SERVED ON ADVISORY PANELS, WORK GROUPS AND EXPERT FORUMS TO BUILD VISIBILITY AND AWARENESS OF OUR MISSION. MEDIA PROGRAM AICR HAD SOLID MEDIA COVERAGE IN NATIONAL PRINT AND ONLINE OUTLETS AS WELL AS TV AND RADIO STATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART III, LINE 4B, CONTINUED.</FormAndLineReferenceDesc>
        <ExplanationTxt>EXTERNAL EVENTS 2023 PRESENT: CO-CHAIR OF CANCER MIG, AMERICAN COLLEGE OF LIFESTYLE MEDICINE (ACLM) 2022 PRESENT: CHAIR OF INTERNATIONAL CANCER RESEARCH PARTNERSHIP (ICRP) PRESENTATIONS 2024/03/16: "GLOBAL EVIDENCE ON PHYSICAL ACTIVITY AND RELATED HEALTH BEHAVIORS ON QUALITY OF LIFE AND SURVIVAL IN CANCER SURVIVORS" SOCIETY OF BEHAVIORAL MEDICINE 45TH ANNUAL MEETING, PHILADELPHIA, PENNSYLVANIA, UNITED STATES 2024/03/15: "MEET THE FUNDERS - MOVING BEHAVIORAL SCIENCE UPSTREAM" SOCIETY OF BEHAVIORAL MEDICINE 45TH ANNUAL MEETING, PHILADELPHIA, PENNSYLVANIA, UNITED STATES 2024/03/14: "PRAGMATISM VS PERFECTION: WHEN IS RESEARCH EVIDENCE GOOD ENOUGH TO GIVE ADVICE?" CO-PRESENTERS: KATHRYN SCHMITZ, PHD, MPH, MONICA BASKIN, PHD, CLAUDIO NIGG, PHD SANDRA MITCHELL, PHD, CRNP. SOCIETY OF BEHAVIORAL MEDICINE 45TH ANNUAL MEETING, PHILADELPHIA, PENNSYLVANIA, UNITED STATES 2023/11/09: UNDERSTANDING THE ROLE OF LIFESTYLE ACROSS THE CANCER CARE CONTINUUM (PANEL DISCUSSION). FUTURE OF CANCER CARE SUMMIT, TAMPA FLORIDA, UNITED STATES AICR RESEARCH PROGRAMS MANAGER PRESENTED ABOUT THE AICR/WCRF CANCER RECOMMENTATIONS AT THE CANCER SURVIVORSHIP RESEARCH MEETING (VIRTUAL), UNIVERSITY OF SOUTH CAROLINA, MARCH 22, 2024 AICR RESEARCH PROGRAMS MANAGER PRESENTED ABOUT THE INSPIRE GRANT CHALLENGE AT THE INTERNATIONAL CANCER RESEARCH PARTNERSHIP, MAY 15, 2024 WEBINARS/PODCASTS 2023/10/17: DIET &amp; LIFESTYLE FOR CANCER PREVENTION AND SURVIVORSHIP EVIDENCE OVER OPINION. OLDWAYS PRESERVATION TRUST SPECIAL WEBINAR 01/25/2024: BLUE CURE PODCAST WITH GABE CANALES ("OBESITY AND CANCER RISK") 02/15/2024: DHL CANCER PREVENTION MONTH WEBINAR (PANELISTS DRS BROCKTON &amp; PADEN) PEER-REVIEWED PUBLICATIONS TSILIDIS K, MARKOZANNES G, BECERRA-TOMS N, CARIOLOU M, BALDUCCI K, VIEIRA AR, KISS S, AUNE D, GREENWOOD D, DOSSUS L, GONZALEZ GIL E, GUNTER MJ, ALLEN K, BROCKTON NT, CROKER H, GORDON-DSEAGU V, MITROU P, MUSUWO N, WISEMAN MJ, COPSON E, RENEHAN AG, BOURS M, DEMARK-WAHNEFRIED W, HUDSON M, MAY AM, ODEDINA FT, SKINNER R, STEINDORF K, TJONNELAND A, VELIKOVA G, BASKIN ML, CHOWDHURY R, HILL L, LEWIS S, SEIDELL J, WEIJENBERG M, KREBS J, CROSS A, CHAN D. POST-DIAGNOSIS ADIPOSITY, PHYSICAL ACTIVITY, SEDENTARY BEHAVIOUR, DIETARY FACTORS, SUPPLEMENT USE AND COLORECTAL CANCER PROGNOSIS: GLOBAL CANCER UPDATE PROGRAMME (CUP GLOBAL) INTERNATIONAL JOURNAL OF CANCER. 2024, 155(3), 471485. (AUGUST) BOOK CHAPTER COMANDER A, SULLIVAN C, BROCKTON N. CANCER. IN: FRATES B, HIVERT M, DUGGAN CP. EDS. ESSENTIALS OF CLINICAL NUTRITION IN HEALTHCARE. MCGRAW HILL; 2024. (JUNE)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 990 FORM IS REVIEWED BY KEY STAFF IN THE AICR ACCOUNTING DEPARTMENT. THE 990 FORM IS THEN REVIEWED BY AICR EXECUTIVE MANAGEMENT, RSM TAX AND THE LAW FIRM STEPTOE &amp; JOHNSON.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE INSTITUTE'S BOARD OF DIRECTORS HAS A CONFLICT OF INTEREST POLICY IN EFFECT. A COPY OF THE POLICY IS PROVIDED TO EACH DIRECTOR, OFFICER AND STAFF MEMBER OF AICR WHO IS PRESENTLY SERVING IN A CAPACITY WHERE A CONFLICT OF INTEREST COULD ARISE. THE POLICY IS REVIEWED ANNUALLY. IF THE BOARD DETERMINES THAT CHANGES DO NOT NEED TO BE MADE, THE POLICY IS REAFFIRMED. NEW DIRECTORS, OFFICERS, AND STAFF MEMBERS ARE ADVISED OF THE POLICY IN EFFECT UPON TAKING OFFICE OR UPON THE START OF EMPLOYMENT, AS THE CASE MAY BE. SINCE FISCAL YEAR 2010, DIRECTORS, OFFICERS, EXECUTIVES, AND SENIOR LEVEL MANAGEMENT STAFF HAVE BEEN REQUIRED TO SIGN A "DECLARATION OF LACK OF CONFLICT OF INTEREST." THE POLICY PROVIDES THAT IN THE EVENT OF A CONFLICT OF INTEREST RELEVANT TO A MATTER REQUIRING ACTION BY THE BOARD, THE PERSON SHALL CALL IT TO THE ATTENTION OF THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), AND SUCH PERSON SHALL NOT VOTE ON THE MATTER. THE PERSON HAVING A CONFLICT OF INTEREST SHALL PROVIDE THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), WITH ANY AND ALL RELEVANT INFORMATION, AND SHALL RETIRE FROM THE ROOM IN WHICH THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE) IS MEETING CONCERNING SUCH MATTER, AND SHALL NOT PARTICIPATE IN THE FINAL DELIBERATION OR DECISION REGARDING THE MATTER UNDER CONSIDERATION. THE MINUTES OF THE MEETING OF THE BOARD (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE) SHALL REFLECT THAT THE CONFLICT OF INTEREST WAS DISCLOSED AND THAT THE INTERESTED PERSON WAS NOT PRESENT DURING THE FINAL DISCUSSION OF SUCH MATTER OR VOTE AND DID NOT VOTE ON SUCH MATTER. WHEN THERE IS A DOUBT AS TO WHETHER A CONFLICT OF INTEREST EXISTS, THE MATTER SHALL BE RESOLVED BY VOTE OF THE BOARD OF DIRECTORS (OR COMMITTEE OF THE BOARD, AS THE CASE MAY BE), EXCLUDING THE INTERESTED PERSON.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE COMPENSATION COMMITTEE, THROUGH A RESOLUTION OF THE AICR BOARD OF DIRECTORS, IS RESPONSIBLE FOR SETTING THE COMPENSATION OF THE PRINCIPAL OFFICERS. THIS COMMITTEE CONDUCTS AN ANNUAL REVIEW OF PERFORMANCE AT THE END OF EACH CALENDAR YEAR AGAINST THE GOALS AND OBJECTIVES ESTABLISHED IN THE YEARLY BUDGETS, THE YEARLY OPERATION PLAN AND THE LONG-TERM STRATEGIC PLANS. INFORMATION UTILIZED IN DETERMINING COMPENSATION ADJUSTMENTS FOR THIS REPORTING PERIOD INCLUDE: 1) REPORT FROM THE EXECUTIVE TEAM FOR THE CALENDAR YEAR; 2) FISCAL YEAR PERFORMANCE AND EFFECTIVENESS ASSESSMENT REPORT; 3) HRA-NCA COMPENSATION SURVEY; 4) AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES ASSOCIATION COMPENSATION AND BENEFITS REPORT; 5) GUIDESTAR COMPENSATION REPORT 5) NONPROFIT TIMES NONPROFIT SALARY AND BENEFITS REPORT. AFTER REVIEWING COMPENSATION STUDIES AND OTHER INDUSTRY INFORMATION, COMPENSATION IS DETERMINED AND AWARDED. INCREASES ARE CONSISTENT WITH COMPENSATION PAID BY ORGANIZATIONS SIMILAR TO AICR HAVING COMPARABLE RESPONSIBILITY AND DUTIES. INCREASES ARE DOCUMENTED AND A MEMO IS DRAFTED FROM THE COMPENSATION COMMITTEE TO THE SENIOR VICE PRESIDENT OF FINANCE, HUMAN RESOURCE FILE AND TO THE EXECUTIVES RECEIVING THE REVIEW INCLUDING THE INSTRUCTIONS AND DETAILS FOR THE COMPENSATION CHANGES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9:</FormAndLineReferenceDesc>
        <ExplanationTxt>CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT LIABILITY -21,512. NET GAIN ON INTEREST IN PERPETUAL TRUST 116,987. CURRENCY LOSS -22,757. LOSS ON TERMINATION OF LEASE -29,945.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PROCESS FOR OVERSEEING THE AUDIT OF THE FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT THAT AUDITED THE FINANCIAL STATEMENTS HAS BEEN CONSISTENT WITH PRIOR YEARS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>WORLD CANCER RESEARCH FUND</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <ForeignAddress>
          <AddressLine1Txt>140 PENTONVILLE RD</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>N1 9FW</ForeignPostalCd>
        </ForeignAddress>
        <PrimaryActivitiesTxt>AFFILIATED CHARITY</PrimaryActivitiesTxt>
        <LegalDomicileForeignCountryCd>UK</LegalDomicileForeignCountryCd>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>AICR</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>1</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>WCRF (TRADING) LTD</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <ForeignAddress>
          <AddressLine1Txt>1 BLOSSOM YARD FOURTH FLOOR</AddressLine1Txt>
          <CityNm>LONDON</CityNm>
          <CountryCd>UK</CountryCd>
          <ForeignPostalCd>E1 6RS</ForeignPostalCd>
        </ForeignAddress>
        <PrimaryActivitiesTxt>LIST RENTAL</PrimaryActivitiesTxt>
        <LegalDomicileForeignCountryCd>UK</LegalDomicileForeignCountryCd>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>WORLD CANCER RESEARCH FUND</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <EntityTypeTxt>C</EntityTypeTxt>
        <ControlledOrganizationInd>0</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>CHARITABLE REMAINDER TRUST</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <USAddress>
          <AddressLine1Txt>1560 WILSON BOULEVARD SUITE 1000</AddressLine1Txt>
          <CityNm>ARLINGTON</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22209</ZIPCd>
        </USAddress>
        <PrimaryActivitiesTxt>UNITRUST</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>CA</LegalDomicileStateCd>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <EntityTypeTxt>T</EntityTypeTxt>
        <ControlledOrganizationInd>0</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>PERPETUAL TRUST</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <USAddress>
          <AddressLine1Txt>1560 WILSON BOULEVARD SUITE 1000</AddressLine1Txt>
          <CityNm>ARLINGTON</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22209</ZIPCd>
        </USAddress>
        <PrimaryActivitiesTxt>PERPETUAL TRUST</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>PA</LegalDomicileStateCd>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <EntityTypeTxt>T</EntityTypeTxt>
        <ControlledOrganizationInd>0</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>1</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>0</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>0</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>0</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>0</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>0</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>1</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>0</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>WORLD CANCER RESEARCH FUND</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>Q</TransactionTypeTxt>
        <InvolvedAmt>94144</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>WORLD CANCER RESEARCH FUND</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>B</TransactionTypeTxt>
        <InvolvedAmt>326268</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART IV, COLUMN (C):</FormAndLineReferenceDesc>
        <ExplanationTxt>A CHARITABLE REMAINDER TRUST IS DOMICILED IN CALIFORNIA.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleR>
  </ReturnData>
</Return>